| 國立成功大學 |
2024-12-31 |
Treatment pattern among patients with relapsed/refractory multiple myeloma (RRMM) who had received pomalidomide-based regimens in Taiwan
|
Teng, Jerry;Chieh-Lin;Yeh;Su-Peng;Chen;Tsai-Yun;Hung;Yu-Chin;Lin;Yun-Chu;Li;Syue, Sin;Wang;Ming-Chung;Huang;Shang-Yi |
| 國立成功大學 |
2024-11-5 |
Trial in Progress: Odronextamab for the Treatment of Patients with Relapsed/Refractory Mantle Cell Lymphoma Following Prior BTK Inhibitor Therapy - a Cohort of the ELM-2 Study
|
Cho;Seok-Goo;Kim;Min, Tae;Taszner;Michal;Chen;Tsai-Yun;Choudhry;Aafia;Ufkin;Melanie;Uppala;Amulya;Sabir;Ayesha;Mohamed;Hesham;Ambati;Srikanth;Bachy;Emmanuel |
| 國立成功大學 |
2024-11-5 |
Outcomes By Refractory Status and Prior Therapies Received in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) from the ECHELON-3 Study
|
Hahn;Uwe;Bartlett;Nancy, L.;Kim;Jeong-A;Bouabdallah;Krimo;Forward;Nicholas;Chen;Tsai-Yun;Camus;Vincent;Wang;Ming-Chung;Carassou;Philippe;Derenzini;Enrico;Chang;Hung;Offner;Fritz;Ghesquieres;Herve;Nowakowski;Grzegorz, S.;Yasenchak;Christopher;Patterson;Monica;Ho;Linda;Rustia;Evelyn;Fanale;Michelle;Fenton;Keenan;Portell;Craig, A. |
| 國立成功大學 |
2024-11-5 |
A Phase 3, Randomized, Double-Blind, Active-Comparator-Controlled Study of Bomedemstat Versus Hydroxyurea in Patients with Essential Thrombocythemia Naive to Cytoreductive Therapy
|
Sugimoto;Yuka;Zimran;Eran;Shimomura;Yoshimitsu;Yamaguchi;Hiroki;Hasselbach;Carl, Hans;Kiladjian;Jean-Jacques;Koschmeider;Steffen;Gill;Harinder;Pettit;Kristen;Ross;David, M.;Harrison;Claire;Berkovits;Alejandro;Demir;Muzaffer, Ahmet;Chen;Tsai-Yun;Scheding;Stefan;Carmona;Barrera, Claudia;Vannuchi;Alessandro;Zhang;Shiyu;Ogbu;Uzor, C.;Kirito;Keita |
| 國立成功大學 |
2024-11-5 |
Sequential Bruton Tyrosine Kinase Inhibitor Therapy in Relapsed or Refractory Mantle Cell Lymphoma Following Chemotherapy: Real-World Outcomes and Attrition Rates- an Updated Report from the Asia-Pacific Multinational Retrospective Registry
|
Cho;Hyungwoo;Yoon;Hyun, Dok;Chan;Yongsheng, Jason;Kim;Dajung;Huang;Haiwen;Cai;Qingqing;Lin;Tongyu;Kato;Koji;Bunworasate;Udomsak;Tan;Mui, Sen;Kang;Ka-Won;Kwak;Jae-Yong;Chen;Tsai-Yun;Lee;Jeong-Ok;Jeong;Hyun, Seong;Do;Rok, Young;Chan;Esther;Kang;Jin, Hye;Uhm;Hyun-Seok;Oh;Yong, Sung;Koh;Youngil;Kim;Jung, Hyo;Kim;Hyung, Se;Won;Ho, Jong;Park;Hoon, Young;Yang;Deok-Hwan;Ng;Chin, Soo;Jo;Jae-Cheol;Kim;Seog, Won |
| 國立成功大學 |
2024-11-5 |
Multicenter, Open-Label Phase 1/2a Study of Pxs-5505 and Ruxolitinib in Patients with Primary, Post-Polycythemia Vera (PV) or Post-Essential Thrombocythemia (ET) Myelofibrosis
|
Tan;Peter;Baker;Ross;Lee;Sung-Eun;Watson;Marie, Anne;Cheung;Stanley;Wu;Shang-Ju;Chen;Chih-Cheng;Tan;Shuhying;Vachhani;Pankit;Chen;Tsai-Yun;Lee;Hoon, Jae;Hsiao;Hui-Hua;Lee;Yun, Ji;Lee;Sik, Won;Masarova;Lucia;Baskar;Jana;Jarolimek;Wolfgang;Leadbetter;Joanna |
| 國立成功大學 |
2024-11 |
Cytoplasmic Lipid Droplets Predict Worse Prognosis in Diffuse Large B-Cell Lymphoma
|
Wang;Shu-Hsien;Chiang;Po-Min;Su;Yung-Yeh;Yu;Yu-Ting;Chen;Ya-Ping;Chen;Tsai-Yun;Medeiros;Jeffrey, L.;Chu;Chang-Yao;Chen;Peng-Chieh;Chang;Kung-Chao |
| 國立成功大學 |
2024-06-01 |
Glofitamab as a salvage treatment for B-cell lymphomas in the real world: A multicenter study in Taiwan
|
Hsu;Ya-Ting;Wu;Shang-Ju;Kao;Hsiao-Wen;Hsiao;Sheng-Yen;Liao;Chun-Kai;Chen;Tsai-Yun;Wang;Ming-Chung |
| 國立成功大學 |
2024-06 |
The potential value of a quantitative PCR assay for assessing respiratory samples in approaching a laboratory diagnosis of pulmonary mucormycosis
|
Chen;Ya-Ping;Cia;Cong-Tat;Hsu;Ya-Ting;Chen;-Lin, Po;Chen;Tsai-Yun;Lee;Jen-Chieh;Li;Sin-Syue;Hsieh;Ming-;I;Wang;Hsuan-Chen;Wu;Chi-Jung |
| 國立成功大學 |
2024-06 |
Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in TaiWan
|
Huang;Yi-Che;Hsiao;Fei-Yuan;Guan;-Ting, Shang;Yao;Ming;Liu;Chia-Jen;Chen;Tzu-Ting;Lin;Tung-Liang;Liu;Yi-Chang;Chen;Tsai-Yun;Hong;Ying-Chung;Ma;Ming-Chun;Tan;Tran-Der;Wang;Chuan-Cheng;Wu;Yi-Ying;Liao;-Wei, Po;Wu;Yi-Feng;Chen;Yi-Yang;Yu;Yuan-Bin;Hsieh;Yao-Yu;Lee;Ming-Yang;Liu;Jia-Hau;Lin;Shu-Wen;Ko;Bor-Sheng |
